BTL Aesthetics
An evidence-first global regulatory and corporate analysis of BTL Aesthetics. We examine registry records across 15+ countries, its direct-subsidiary structure, and…
Ultherapy, Sofwave, Thermage FLX, Plasma fibroblast. Ultrasound vs RF vs hybrid — and the limits of non-surgical lift.
An evidence-first global regulatory and corporate analysis of BTL Aesthetics. We examine registry records across 15+ countries, its direct-subsidiary structure, and…
BTL Aesthetics is the force behind Emsculpt Neo, Emface, and Emsella. We analyze their complete FDA 510(k) clearances, indications, safety record, and the regulatory…
Venus Concept's aesthetic footprint spans Venus Legacy, Viva, and Bliss. We examine their complete FDA 510(k) approvals, safety record, and the major 2026 corporate…
A regulatory and safety profile of Alma Lasers' portfolio, analyzing its 26 FDA clearances, Soprano and Harmony lineages, Sisram Medical ownership, and openFDA MAUDE…
A regulatory and safety profile of Fotona's portfolio, analyzing its 38 FDA clearances, SP Dynamis dual-wavelength platform, NightLase snoring protocol, and MAUDE record.
Profiles Sciton's aesthetic device portfolio, its 21 FDA 510(k) clearances, BBL gene-expression evidence, and openFDA MAUDE safety record.
Profiles Solta Medical's aesthetic device footprint, its 32 FDA 510(k) clearances, openFDA MAUDE post-market safety records, and corporate ownership under Bausch Health.
A comprehensive regulatory dossier mapping InMode's RF technology architecture (Morpheus8, BodyTite, FaceTite), FDA 510(k) clearances, and post-market safety…
Emface pairs synchronized radiofrequency with HIFES facial-muscle stimulation. We break down what the FDA cleared it for, what the small manufacturer studies show, and…
Plasma pens bypass FDA cosmetic reviews, but voluntary MAUDE databases reveal severe risks of atrophic scarring and hypopigmentation requiring costly laser corrections.